| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.7 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.062 | 0.7 |